A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres.

[1]  Qin-yuan Zhu,et al.  Toxic Epidermal Necrolysis: Performance of SCORTEN and the Score-Based Comparison of the Efficacy of Corticosteroid Therapy and Intravenous Immunoglobulin Combined Therapy in China , 2012, Journal of burn care & research : official publication of the American Burn Association.

[2]  B. Pollock,et al.  Toxic epidermal necrolysis: five years of treatment experience from a burn unit. , 2012, Journal of the American Academy of Dermatology.

[3]  F. von Groote-Bidlingmaier,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study. , 2012, QJM : monthly journal of the Association of Physicians.

[4]  M. Struck,et al.  Secondary abdominal compartment syndrome in patients with toxic epidermal necrolysis. , 2012, Burns : journal of the International Society for Burn Injuries.

[5]  A. Cooper,et al.  Toxic epidermal necrolysis: review of pathogenesis and management. , 2012, Journal of the American Academy of Dermatology.

[6]  R. Zajíček,et al.  Toxic epidermal necrolysis and Stevens‐Johnson syndrome at the Prague Burn Centre 1998–2008 , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  C. Bouchard,et al.  Management of Ocular Conditions in the Burn Unit: Thermal and Chemical Burns and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis , 2011, Journal of burn care & research : official publication of the American Burn Association.

[8]  M. Nelle,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review* , 2011, Critical care medicine.

[9]  R. Ferner,et al.  Patient Experiences of Serious Adverse Drug Reactions and Their Attitudes to Medicines , 2011, Drug safety.

[10]  L. Naldi,et al.  Evaluation of SCORTEN on a Cohort of Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Included in the RegiSCAR Study , 2011, Journal of burn care & research : official publication of the American Burn Association.

[11]  N. Moiemen,et al.  Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre , 2010, Clinical and experimental dermatology.

[12]  R. Cartotto,et al.  What Are the Fluid Requirements in Toxic Epidermal Necrolysis? , 2010, Journal of burn care & research : official publication of the American Burn Association.

[13]  L. Brochard,et al.  Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Epidemiology, Risk Factors, and Predictive Value of Skin Cultures , 2010, Medicine.

[14]  N. Noviski,et al.  Toxic Epidermal Necrolysis in Children: Medical, Surgical, and Ophthalmologic Considerations , 2009, Journal of burn care & research : official publication of the American Burn Association.

[15]  L. Cancio,et al.  Toxic epidermal necrolysis clinical guidelines. , 2008, Journal of burn care & research : official publication of the American Burn Association.

[16]  A. Ugburo,et al.  A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country. , 2008, Burns : journal of the International Society for Burn Injuries.

[17]  L. Gottlieb,et al.  Antishear Therapy for Toxic Epidermal Necrolysis: An Alternative Treatment Approach , 2008, Plastic and reconstructive surgery.

[18]  M. Spies,et al.  Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. , 2008, Burns : journal of the International Society for Burn Injuries.

[19]  Sin-Daw Lin,et al.  AQUACEL® Ag in the treatment of toxic epidermal necrolysis (TEN) , 2008 .

[20]  R. Cartotto,et al.  SCORTEN Accurately Predicts Mortality Among Toxic Epidermal Necrolysis Patients Treated in a Burn Center , 2008, Journal of burn care & research : official publication of the American Burn Association.

[21]  R. Gamelli,et al.  Treatment Strategies in Toxic Epidermal Necrolysis Syndrome: Where Are We At? , 2008, Journal of burn care & research : official publication of the American Burn Association.

[22]  R. Salisbury,et al.  Morbidity and Mortality of Mucocutaneous Diseases in the Pediatric Population at a Tertiary Care Center , 2007, Journal of burn care & research : official publication of the American Burn Association.

[23]  R. Gamelli,et al.  DRG 272: Does it Provide Adequate Burn Center Reimbursement for the Care of Patients With Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis? , 2007, Journal of burn care & research : official publication of the American Burn Association.

[24]  P. Maitz,et al.  TOXIC EPIDERMAL NECROLYSIS/STEVENS–JOHNSON SYNDROME: CURRENT TRENDS IN MANAGEMENT , 2007, ANZ journal of surgery.

[25]  G. Gravante,et al.  Toxic epidermal necrolysis and Steven-Johnson syndrome in oncologic patients. , 2007, European review for medical and pharmacological sciences.

[26]  M. Stella,et al.  Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. , 2007, Burns : journal of the International Society for Burn Injuries.

[27]  G. Gravante,et al.  Toxic epidermal necrolysis and Steven Johnson syndrome: 11-years experience and outcome. , 2007, European review for medical and pharmacological sciences.

[28]  D. Rosmarin,et al.  Toxic epidermal necrolysis. , 2007, Journal of the American Academy of Dermatology.

[29]  G. Gravante,et al.  More than two different bacterial species isolated from blood of toxic epidermal necrolysis patients significantly increase mortality. , 2006, Burns : journal of the International Society for Burn Injuries.

[30]  D. Heimbach,et al.  SCORTEN Overestimates Mortality in the Setting of a Standardized Treatment Protocol , 2006, Journal of burn care & research : official publication of the American Burn Association.

[31]  L. French,et al.  Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. , 2006, International immunopharmacology.

[32]  R. Gamelli,et al.  Long-Term Follow-Up of Patients Treated for Toxic Epidermal Necrolysis , 2006, Journal of burn care & research : official publication of the American Burn Association.

[33]  R. Kirsner,et al.  Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. , 2004, Archives of dermatology.

[34]  R. Cartotto,et al.  Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. , 2004, The Journal of burn care & rehabilitation.

[35]  H. Shimizu,et al.  Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. , 2003, The American journal of pathology.

[36]  R. Gamelli,et al.  Toxic Epidermal Necrolysis Syndrome: Does IgG Make a Difference?: 89. , 2003 .

[37]  W. Rising,et al.  Outcome of Patients with Toxic Epidermal Necrolysis Syndrome Revisited , 2002, Plastic and reconstructive surgery.

[38]  L. Naldi,et al.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. , 2002, Archives of dermatology.

[39]  S. Ying,et al.  Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong. , 2001, Burns : journal of the International Society for Burn Injuries.

[40]  R. Sheridan,et al.  A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. , 2001, The Journal of burn care & rehabilitation.

[41]  C. Ryan,et al.  A 10-year experience with toxic epidermal necrolysis. , 2000, The Journal of burn care & rehabilitation.

[42]  J. Rohr,et al.  Toxic epidermal necrolysis in Western Australia , 2000, The Australasian journal of dermatology.

[43]  E. C. Smoot,et al.  Treatment issues in the care of patients with toxic epidermal necrolysis. , 1999, Burns : journal of the International Society for Burn Injuries.

[44]  P. Kennedy,et al.  Clinical manifestations and outcomes in 17 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis , 1999, The Australasian journal of dermatology.

[45]  A. Munster,et al.  Toxic Epidermal Necrolysis Syndrome: Mortality Rate Reduced with Early Referral to Regional Burn Center , 1998, Plastic and reconstructive surgery.

[46]  J. Roujeau,et al.  Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study , 1997, Intensive Care Medicine.

[47]  M. Schurr,et al.  Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage. , 1997, The Journal of burn care & rehabilitation.

[48]  J. Hunt,et al.  Toxic epidermal necrolysis. , 1997, The Journal of burn care & rehabilitation.

[49]  A. Khoo,et al.  Toxic epidermal necrolysis in a burns centre: a 6-year review. , 1996, Burns : journal of the International Society for Burn Injuries.

[50]  L. Hughes-Davies,et al.  Severe adverse cutaneous reactions to drugs. , 1995, The New England journal of medicine.

[51]  A. Mason,et al.  Burn center care for patients with toxic epidermal necrolysis. , 1995, Journal of the American College of Surgeons.

[52]  J. Roujeau,et al.  Toxic epidermal necrolysis: an expanding field of knowledge. , 1994, Journal of the American Academy of Dermatology.

[53]  D. Ioannides,et al.  Toxic epidermal necrolysis: a study of 22 cases , 1994 .

[54]  J. Roujeau,et al.  Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients. , 1993, Age and ageing.

[55]  J. Still,et al.  An approach to the management of toxic epidermal necrolysis in a burn centre. , 1993, Burns : journal of the International Society for Burn Injuries.

[56]  P. Suthipinittharm,et al.  STEVENS‐JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS IN THAILAND , 1993, International journal of dermatology.

[57]  Walter Peters,et al.  Toxic epidermal necrolysis: a burn-centre challenge. , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[58]  J. Roujeau,et al.  Toxic epidermal necrolysis (Lyell syndrome). , 1990, Journal of the American Academy of Dermatology.

[59]  N. Tanner,et al.  Treatment of toxic epidermal necrolysis and a review of six cases. , 1990, Burns : journal of the International Society for Burn Injuries.

[60]  J. Roujeau,et al.  Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. , 1987, Archives of dermatology.

[61]  D. Heimbach,et al.  Toxic Epidermal Necrolysis: A Step Forward in Treatment , 1987 .

[62]  G. Shires,et al.  Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without Corticosteroids , 1986, Annals of surgery.

[63]  A. Munster,et al.  The Parkland formula in patients with burns and inhalation injury. , 1982, The Journal of trauma.

[64]  J. Gõmez Orbaneja,et al.  [Toxic epidermal necrolysis]. , 1967, Revista clinica espanola.

[65]  K. Shilkin,et al.  TOXIC EPIDERMAL NECROLYSIS (LYELL'S DISEASE) , 1966, Australian journal of dermatology.

[66]  A. Lyell.  TOXIC EPIDERMAL NECROLYSIS: AN ERUPTION RESEMBLING SCALDING OF THE SKIN. , 1956, The British journal of dermatology.

[67]  A. Vloemans,et al.  Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre. , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[68]  Z. Ikezawa,et al.  Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. , 2007, Allergology international : official journal of the Japanese Society of Allergology.

[69]  C. Meuli‐Simmen,et al.  Lyell syndrome revisited: analysis of 18 cases of severe bullous skin disease in a burns unit. , 2005, British journal of plastic surgery.

[70]  R. Cartotto,et al.  Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center. , 2005, The Journal of burn care & rehabilitation.

[71]  R. Gamelli,et al.  Toxic epidermal necrolysis: does immunoglobulin make a difference? , 2004, The Journal of burn care & rehabilitation.

[72]  Manuel Gomez,et al.  Evaluation of the Extent of Under-Reporting of Serious Adverse Drug Reactions , 2004, Drug safety.

[73]  J. Roujeau,et al.  Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. , 2003, Archives of dermatology.

[74]  R. S. Padilla,et al.  Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. , 2003, Archives of dermatology.

[75]  D. Heimbach,et al.  Toxic epidermal necrolysis (TEN) in elderly patients. , 2001, The Journal of burn care & rehabilitation.

[76]  D. Yarbrough.  Experience with toxic epidermal necrolysis treated in a burn center. , 1996, The Journal of burn care & rehabilitation.

[77]  日本アレルギー学会.  Allergology international : official journal of the Japanese Society of Allergology , 1996 .

[78]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .